Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l'urine et l'usag…

Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment.  Theisen J, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Cheng A, Blakemore S, Blodgett J, Fielman S, Saitz R, Bazzi AR. …

A look beyond the needle: high prevalence of injecting risk behaviours among people who inject drugs in Zanzibar.  Kibusi SM, Mohamed KK, Stephano EE, Joho AA, Nyundo A, Mpondo BCT.  BMC Public Health. 2025 Aug 2;25(1):2623. doi: 10.1186…

Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood.  Monfared A, Murrell DE, Shah DS, Hoang M, Brown SD, Harirforoosh S.  Toxicol Rep. 2025 Jul 20;15:102093. doi: 10.1016/j.toxrep.2025.102093. PM…

Optimizing pharmacologic treatment for neonatal opioid withdrawal syndrome (OPTimize NOW): a symptom-based dosing approach study protocol for a multi-center, cluster crossover design randomized controlled trial.  Young LW, Babineau DC, Das A…

The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates.  Isohata H, Miura S, Yamazaki Y, Goto H, Yoshimura Y, Hattori K, Shimaoka T, Sekiguchi K, Nak…